double dose of tirzepatide dosage chart for weight loss At a glance factsheet: Tirzepatide
Description
Eli Lillys ATTAIN-1 trial showed an average weight loss of 14% over 72 weeks with the highest dose of orforglipron, containing 36 mg of the active ingredient
Research has shown that individuals taking higher doses of the medication tend to experience greater reductions in appetite and body weight
How Do GLP1s Work
Nevertheless, its unlikely that lower doses would lead to higher safety concerns
Treatment is month-to-month with no long-term contracts, so you can reassess goals and continue or pause treatment based on your results and life circumstances
